Unique ID issued by UMIN | UMIN000014950 |
---|---|
Receipt number | R000017389 |
Scientific Title | Evaluation of serum miR-221/222 as novel tumor markers |
Date of disclosure of the study information | 2014/10/01 |
Last modified on | 2019/05/10 19:00:51 |
Evaluation of serum miR-221/222 as novel tumor markers
Evaluation of serum miR-221/222 as novel tumor markers
Evaluation of serum miR-221/222 as novel tumor markers
Evaluation of serum miR-221/222 as novel tumor markers
Japan |
esophageal cancer, gastric cancer, colorectal cancer, pancreatic cancer, bile duct cancer, and healthy controls
Medicine in general | Gastroenterology | Endocrinology and Metabolism |
Malignancy
NO
The aim of this study is to evaluate the clinical usefulness of serum miR-221/222 as tumor markers. Especially we evaluate the association between the presence of colorectal adenoma or adenocarcinoma and serum miR-221/222 levels.
Others
Development of novel tumor markers using blood samples
Presence of colorectal adenoma or gastrointestinal cancers
Observational
20 | years-old | <= |
Not applicable |
Male and Female
- Participants undergoing colonoscopy in the Center for Preventive Medicine, Keio University Hospital.
- Inpatients with untreated gastrointestinal cancers in Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University Hospital.
- Participants from whom we failed to take blood samples.
- Participants who answered questionnaires incompletely.
- Participants who did not undergo CT scan for calculating visceral fat areas.
220
1st name | Yasushi |
Middle name | |
Last name | Iwao |
Keio University Hospital
Center for Preventive Medicine
160-8582
35 Shinanomachi, Shinjuku-ku, Tokyo, JAPAN
03-6910-3533
iwao@keio.jp
1st name | Juntaro |
Middle name | |
Last name | Matsuzaki |
Keio University Hospital
Center for Preventive Medicine
160-8582
35 Shinanomachi, Shinjuku-ku, Tokyo, JAPAN
03-5363-3914
juntaro.matsuzaki@gmail.com
Keio University
Takeda Science Foundation
Non profit foundation
Keio University School of Medicine Ethics Committee
35 Shinanomachi, Shinjuku-ku, Tokyo, JAPAN
03-3353-1211
med-rinri-jimu@adst.keio.ac.jp
NO
2014 | Year | 10 | Month | 01 | Day |
Unpublished
Completed
2014 | Year | 07 | Month | 25 | Day |
2014 | Year | 07 | Month | 25 | Day |
2015 | Year | 02 | Month | 01 | Day |
2019 | Year | 04 | Month | 08 | Day |
Using obtained blood samples, following values are measured.
serum miR-221/222, metabolic syndrome-related paramaters (LOX, MMP2, MMP9, Cathepsin S, Cathepsin D, cathepsin L, cathepsin B)
In addition, medical records are reviewed.
2014 | Year | 08 | Month | 25 | Day |
2019 | Year | 05 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017389
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |